Vikram Khurana, M.B.,B.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| alpha-Synuclein | 17 | 2024 | 724 | 2.650 |
Why?
|
| Multiple System Atrophy | 4 | 2024 | 122 | 1.890 |
Why?
|
| Parkinson Disease | 16 | 2024 | 2774 | 1.740 |
Why?
|
| Neurodegenerative Diseases | 8 | 2023 | 1060 | 1.320 |
Why?
|
| Supranuclear Palsy, Progressive | 2 | 2022 | 77 | 1.040 |
Why?
|
| Proteostasis Deficiencies | 1 | 2020 | 38 | 0.720 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 145 | 0.710 |
Why?
|
| Ataxia | 1 | 2021 | 304 | 0.680 |
Why?
|
| Saccharomyces cerevisiae | 7 | 2018 | 2749 | 0.670 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2023 | 1728 | 0.650 |
Why?
|
| Prions | 2 | 2017 | 181 | 0.610 |
Why?
|
| Tauopathies | 3 | 2012 | 307 | 0.580 |
Why?
|
| Neurons | 14 | 2024 | 9325 | 0.550 |
Why?
|
| Peroxidase | 1 | 2019 | 610 | 0.530 |
Why?
|
| In Situ Hybridization | 1 | 2019 | 1950 | 0.500 |
Why?
|
| Mass Spectrometry | 2 | 2019 | 2203 | 0.420 |
Why?
|
| tau Proteins | 3 | 2010 | 1860 | 0.390 |
Why?
|
| Cathepsin D | 1 | 2010 | 61 | 0.370 |
Why?
|
| Proteomics | 2 | 2020 | 3618 | 0.350 |
Why?
|
| Protein Conformation | 1 | 2017 | 4013 | 0.350 |
Why?
|
| Drosophila | 5 | 2010 | 1484 | 0.310 |
Why?
|
| Cell Cycle | 2 | 2006 | 2964 | 0.310 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2010 | 290 | 0.280 |
Why?
|
| Nerve Degeneration | 2 | 2006 | 748 | 0.260 |
Why?
|
| Lysosomes | 1 | 2010 | 893 | 0.260 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2005 | 88 | 0.250 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 18006 | 0.240 |
Why?
|
| Purkinje Cells | 1 | 2005 | 223 | 0.240 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2022 | 86 | 0.210 |
Why?
|
| Genetic Testing | 1 | 2015 | 3439 | 0.210 |
Why?
|
| DNA Damage | 1 | 2012 | 2423 | 0.200 |
Why?
|
| Somatosensory Disorders | 1 | 2021 | 47 | 0.200 |
Why?
|
| Receptors, GABA | 1 | 2022 | 288 | 0.190 |
Why?
|
| Decision Trees | 1 | 2022 | 506 | 0.190 |
Why?
|
| Pesticides | 1 | 2023 | 287 | 0.190 |
Why?
|
| Point Mutation | 2 | 2019 | 1624 | 0.180 |
Why?
|
| Drosophila melanogaster | 2 | 2008 | 1704 | 0.180 |
Why?
|
| RNA Stability | 1 | 2022 | 322 | 0.180 |
Why?
|
| Drosophila Proteins | 2 | 2006 | 1699 | 0.180 |
Why?
|
| Animals | 20 | 2022 | 168561 | 0.170 |
Why?
|
| Cytoprotection | 2 | 2018 | 210 | 0.150 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2017 | 68 | 0.140 |
Why?
|
| Gene Regulatory Networks | 2 | 2017 | 1707 | 0.140 |
Why?
|
| Diagnosis, Differential | 2 | 2022 | 12958 | 0.140 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 202 | 0.140 |
Why?
|
| Fatal Outcome | 1 | 2021 | 1849 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 2938 | 0.140 |
Why?
|
| Models, Biological | 2 | 2010 | 9581 | 0.140 |
Why?
|
| Genome, Fungal | 1 | 2017 | 204 | 0.130 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2017 | 1884 | 0.130 |
Why?
|
| Syndrome | 1 | 2021 | 3248 | 0.130 |
Why?
|
| Humans | 32 | 2024 | 742088 | 0.130 |
Why?
|
| Staining and Labeling | 1 | 2019 | 1099 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 2505 | 0.120 |
Why?
|
| Celiac Disease | 1 | 2021 | 785 | 0.110 |
Why?
|
| Yeasts | 1 | 2014 | 285 | 0.110 |
Why?
|
| Pedigree | 1 | 2021 | 4646 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2013 | 168 | 0.110 |
Why?
|
| Amyloid | 1 | 2017 | 795 | 0.110 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2013 | 144 | 0.110 |
Why?
|
| Rats | 5 | 2019 | 24265 | 0.110 |
Why?
|
| Heterozygote | 1 | 2019 | 2790 | 0.110 |
Why?
|
| Mutation, Missense | 2 | 2024 | 2556 | 0.100 |
Why?
|
| Neuroprotective Agents | 2 | 2017 | 941 | 0.100 |
Why?
|
| Models, Animal | 1 | 2017 | 2170 | 0.100 |
Why?
|
| DNA-Binding Proteins | 3 | 2017 | 9639 | 0.100 |
Why?
|
| Movement Disorders | 1 | 2014 | 444 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2017 | 1533 | 0.090 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 1144 | 0.090 |
Why?
|
| Models, Neurological | 2 | 2015 | 1771 | 0.090 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 1780 | 0.090 |
Why?
|
| Neuroglia | 1 | 2015 | 925 | 0.090 |
Why?
|
| Apoptosis | 1 | 2006 | 9715 | 0.090 |
Why?
|
| Disease | 1 | 2015 | 681 | 0.090 |
Why?
|
| Compound Eye, Arthropod | 1 | 2008 | 3 | 0.090 |
Why?
|
| Alzheimer Disease | 3 | 2022 | 7988 | 0.090 |
Why?
|
| Cholecalciferol | 1 | 2013 | 537 | 0.080 |
Why?
|
| Protein Folding | 2 | 2015 | 843 | 0.080 |
Why?
|
| Benzimidazoles | 1 | 2013 | 848 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2019 | 19223 | 0.080 |
Why?
|
| Sheep | 1 | 2010 | 1437 | 0.080 |
Why?
|
| Gerstmann-Straussler-Scheinker Disease | 1 | 2006 | 10 | 0.070 |
Why?
|
| Caspases | 1 | 2010 | 928 | 0.070 |
Why?
|
| Brain | 3 | 2022 | 26343 | 0.070 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 5705 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2006 | 23387 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 2 | 2017 | 3574 | 0.070 |
Why?
|
| Skin | 1 | 2019 | 4353 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2015 | 3493 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 643 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 35342 | 0.060 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 795 | 0.060 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2005 | 242 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 1860 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 1331 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2019 | 8436 | 0.060 |
Why?
|
| Fatty Acids | 2 | 2022 | 1806 | 0.050 |
Why?
|
| Microtubules | 1 | 2008 | 1090 | 0.050 |
Why?
|
| Stem Cells | 1 | 2015 | 3563 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2017 | 13029 | 0.050 |
Why?
|
| Mice | 6 | 2022 | 81045 | 0.050 |
Why?
|
| Motor Skills | 1 | 2004 | 518 | 0.050 |
Why?
|
| Mutation | 2 | 2022 | 29717 | 0.040 |
Why?
|
| Proteins | 1 | 2015 | 6096 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2006 | 3701 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2024 | 867 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 12071 | 0.040 |
Why?
|
| Actins | 1 | 2006 | 2120 | 0.040 |
Why?
|
| Cell Division | 1 | 2006 | 4564 | 0.040 |
Why?
|
| Oxadiazoles | 1 | 2018 | 93 | 0.040 |
Why?
|
| Motor Endplate | 1 | 1998 | 20 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2006 | 1638 | 0.040 |
Why?
|
| Amphibians | 1 | 1998 | 30 | 0.040 |
Why?
|
| Nevada | 1 | 2017 | 22 | 0.040 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2017 | 15 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2006 | 5180 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 53187 | 0.040 |
Why?
|
| Organoids | 1 | 2022 | 692 | 0.040 |
Why?
|
| Synaptic Vesicles | 1 | 1998 | 191 | 0.040 |
Why?
|
| Albuterol | 1 | 2017 | 208 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2006 | 2107 | 0.040 |
Why?
|
| Norway | 1 | 2017 | 446 | 0.030 |
Why?
|
| Motor Cortex | 1 | 2004 | 984 | 0.030 |
Why?
|
| Propranolol | 1 | 2017 | 502 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 2017 | 353 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 11363 | 0.030 |
Why?
|
| Antibodies | 1 | 2024 | 2459 | 0.030 |
Why?
|
| Patient Advocacy | 1 | 2017 | 353 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2010 | 14554 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 1085 | 0.030 |
Why?
|
| Cell Line | 2 | 2024 | 15994 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 24913 | 0.030 |
Why?
|
| Learning | 1 | 2004 | 1705 | 0.030 |
Why?
|
| Memory | 1 | 2004 | 2163 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 77098 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 17400 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 162944 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 556 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2017 | 730 | 0.030 |
Why?
|
| Aging | 1 | 2012 | 8626 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2024 | 3020 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2015 | 810 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2017 | 1239 | 0.030 |
Why?
|
| Protein Transport | 1 | 2017 | 1988 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 1337 | 0.020 |
Why?
|
| Triglycerides | 1 | 2018 | 2450 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 5851 | 0.020 |
Why?
|
| Ligands | 1 | 2017 | 3293 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1887 | 0.020 |
Why?
|
| Male | 4 | 2021 | 349538 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2011 | 572 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 1372 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 721 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4200 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2011 | 1263 | 0.020 |
Why?
|
| Histones | 1 | 2017 | 2597 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 5867 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2011 | 952 | 0.020 |
Why?
|
| Risk | 1 | 2017 | 9679 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 1416 | 0.020 |
Why?
|
| Genome-Wide Association Study | 2 | 2015 | 12220 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 1294 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 7721 | 0.010 |
Why?
|
| Electromagnetic Fields | 1 | 2004 | 298 | 0.010 |
Why?
|
| Thumb | 1 | 2004 | 226 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 5979 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 1546 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2006 | 1185 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16665 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2004 | 1309 | 0.010 |
Why?
|
| Electromyography | 1 | 2004 | 1391 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 13921 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2004 | 2290 | 0.010 |
Why?
|
| Prevalence | 1 | 2013 | 15194 | 0.010 |
Why?
|
| Exocytosis | 1 | 1998 | 353 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 21719 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 15530 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2004 | 1895 | 0.010 |
Why?
|
| Endocytosis | 1 | 1998 | 983 | 0.010 |
Why?
|
| Middle Aged | 2 | 2019 | 213127 | 0.010 |
Why?
|
| Female | 3 | 2019 | 379592 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 213712 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 16331 | 0.010 |
Why?
|